BACKGROUND: Minority racial/ethnic groups have low colorectal cancer (CRC) screening rates. OBJECTIVE: To evaluate a culturally tailored intervention to increase CRC screening, primarily using colonoscopy, among low income and non-English speaking patients. DESIGN: Randomized controlled trial conducted from January to October of 2007. SETTING:Single, urban community health center serving a low-income, ethnically diverse population. PATIENTS: A total of 1,223 patients 52-79 years of age overdue for CRC screening, randomized to intervention (n = 409) vs. usual care control (n = 814) groups. INTERVENTION: Intervention patients received an introductory letter with educational material followed by phone or in-person contact by a language-concordant "navigator." Navigators (n = 5) were community health workers trained to identify and address patient-reported barriers to CRC screening. Individually tailored interventions included patient education, procedure scheduling, translation and explanation of bowel preparation, and help with transportation and insurance coverage. Rates of colorectal cancer screening were assessed for intervention and usual care control patients. RESULTS: Over a 9-month period, intervention patients were more likely to undergo CRC screening than control patients (27% vs. 12% for any CRC screening, p < 0.001; 21% vs. 10% for colonoscopy completion, p < 0.001). The higher screening rate resulted in the identification of 10.5 polyps per 100 patients in the intervention group vs. 6.8 in the control group (p = 0.04). LIMITATIONS: Patients were from one health center. Some patients may have obtained CRC screening outside our system. CONCLUSIONS: A culturally tailored, language-concordant navigator program designed to identify and overcome barriers to colorectal cancer screening can significantly improve colonoscopy rates for low income, ethnically and linguistically diverse patients. ClinicalTrials.gov registration number: NCT00476970.
RCT Entities:
BACKGROUND: Minority racial/ethnic groups have low colorectal cancer (CRC) screening rates. OBJECTIVE: To evaluate a culturally tailored intervention to increase CRC screening, primarily using colonoscopy, among low income and non-English speaking patients. DESIGN: Randomized controlled trial conducted from January to October of 2007. SETTING: Single, urban community health center serving a low-income, ethnically diverse population. PATIENTS: A total of 1,223 patients 52-79 years of age overdue for CRC screening, randomized to intervention (n = 409) vs. usual care control (n = 814) groups. INTERVENTION: Intervention patients received an introductory letter with educational material followed by phone or in-person contact by a language-concordant "navigator." Navigators (n = 5) were community health workers trained to identify and address patient-reported barriers to CRC screening. Individually tailored interventions included patient education, procedure scheduling, translation and explanation of bowel preparation, and help with transportation and insurance coverage. Rates of colorectal cancer screening were assessed for intervention and usual care control patients. RESULTS: Over a 9-month period, intervention patients were more likely to undergo CRC screening than control patients (27% vs. 12% for any CRC screening, p < 0.001; 21% vs. 10% for colonoscopy completion, p < 0.001). The higher screening rate resulted in the identification of 10.5 polyps per 100 patients in the intervention group vs. 6.8 in the control group (p = 0.04). LIMITATIONS: Patients were from one health center. Some patients may have obtained CRC screening outside our system. CONCLUSIONS: A culturally tailored, language-concordant navigator program designed to identify and overcome barriers to colorectal cancer screening can significantly improve colonoscopy rates for low income, ethnically and linguistically diverse patients. ClinicalTrials.gov registration number: NCT00476970.
Authors: Kathleen Ell; Betsy Vourlekis; Laila Muderspach; Jan Nissly; Deborah Padgett; Diana Pineda; Olga Sarabia; Pey-Jiuan Lee Journal: J Womens Health Gend Based Med Date: 2002-09
Authors: Ronald E Myers; Randa Sifri; Terry Hyslop; Michael Rosenthal; Sally W Vernon; James Cocroft; Thomas Wolf; Jocelyn Andrel; Richard Wender Journal: Cancer Date: 2007-11-01 Impact factor: 6.860
Authors: Ann Oluloro; Amanda F Petrik; Ann Turner; Tanya Kapka; Jennifer Rivelli; Patricia A Carney; Somnath Saha; Gloria D Coronado Journal: J Community Health Date: 2016-08
Authors: Karen E Lasser; Karey S Kenst; Lisa M Quintiliani; Renda Soylemez Wiener; Jennifer Murillo; Lori Pbert; Ziming Xuan; Deborah J Bowen Journal: J Ethn Subst Abuse Date: 2013 Impact factor: 1.507
Authors: David R Lairson; Melissa Dicarlo; Ashish A Deshmuk; Heather B Fagan; Randa Sifri; Nora Katurakes; James Cocroft; Jocelyn Sendecki; Heidi Swan; Sally W Vernon; Ronald E Myers Journal: Cancer Date: 2014-01-16 Impact factor: 6.860
Authors: Candace H Feldman; LeRoi S Hicks; Tabatha L Norton; Elmer Freeman; Daniel H Solomon Journal: J Clin Rheumatol Date: 2013-10 Impact factor: 3.517
Authors: Adrian H Zai; Seokjin Kim; Arnold Kamis; Ken Hung; Jeremiah G Ronquillo; Henry C Chueh; Steven J Atlas Journal: J Am Med Inform Assoc Date: 2013-09-16 Impact factor: 4.497
Authors: Ronald E Myers; Randa Sifri; Constantine Daskalakis; Melissa DiCarlo; Praveen Ramakrishnan Geethakumari; James Cocroft; Christopher Minnick; Nancy Brisbon; Sally W Vernon Journal: J Natl Cancer Inst Date: 2014-12-06 Impact factor: 13.506